Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Andrew Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Andrew Technologies

Andrew Technologies

Andrew Technologies: A medical tech firm specializing in stem cell and diabetes solutions.

HQ
Haddonfield, NJ, US
Founded
2007
Overview
Compare
Fundraising
Employees

Andrew Technologies is a medical technology firm dedicated to advancing stem cell and diabetes solutions. The company focuses on developing innovative treatments and technologies to improve patient outcomes in these critical healthcare areas.

Andrew Technologies has made significant strides in medical research and technology, contributing to advancements in stem cell therapies and diabetes management. Their work has garnered attention from the medical community, positioning them as a key player in these specialized fields.

Andrew Technologies - Similar Companies

Antria logo

Antria

antria.org

Infused Medical Technology logo

Infused Medical Technology

Stemtech logo

Stemtech

stemtech.com

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Dawatek logo

Dawatek

Annoviant logo

Annoviant

MobileMedTek logo

MobileMedTek

International Stem Cell logo

International Stem Cell

BiomedInnovations logo

BiomedInnovations

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Stel Technologies logo

Stel Technologies

Spheringenics logo

Spheringenics

Regenerative Medical Solutions logo

Regenerative Medical Solutions

Vitreoretinal Technologies logo

Vitreoretinal Technologies

BioInspire Technologies logo

BioInspire Technologies

Andrew Technologies - Quick Facts

Who are Andrew Technologies' competitors?

Companies similar to Andrew Technologies include Antria, Infused Medical Technology, Stemtech and Advanced Medical Device Technologies.

When was Andrew Technologies founded?

Andrew Technologies was founded in 2007.

Where is Andrew Technologies' headquarters located?

Andrew Technologies' headquarters is located in Haddonfield, NJ, US.

When was Andrew Technologies' last funding round?

Andrew Technologies' most recent funding round was for $7.8M (USD) in December 2015.

How much has Andrew Technologies raised to-date?

As of Dec 9, 2015, Andrew Technologies has raised a total of $24.9M (USD).

How many employees does Andrew Technologies have?

Andrew Technologies has 7 employees as of Feb 5, 2024.

Andrew Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations